HOUSE DOCKET, NO. 4166        FILED ON: 1/17/2025

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No.         

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Homar Gómez and Adam Gomez

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to APOL1 mediated kidney disease.

_______________

PETITION OF:

HOUSE DOCKET, NO. 4166        FILED ON: 1/17/2025

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No.         

The Commonwealth of Massachusetts

_______________

In the One Hundred and Ninety-Fourth General Court
(2025-2026)

_______________

An Act relative to APOL1 mediated kidney disease.

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

Chapter 111 of the General Laws is hereby amended by inserting after section 244, the following section:-

Section 245. The department of public health shall conduct a review and issue a report on variants of the apolipoprotein L 1 (APOL 1) gene associated with increased risk of end-stage renal disease. The report must include:

(1) Recommendations on how to increase awareness for APOL 1, including screening and genetic testing;

(2) An analysis of strategies and funding to increase screening and genetic testing for APOL 1 in the commonwealth; and

(3) Other relevant information or issues identified by the department.

The department of public health shall file the report with the clerks of the house of representatives and the senate and the joint committee on public health no later than December 31, 2026.